PP3252 - Neuropharmacology
|Student Contribution Band:
||College of Public Health, Medical & Vet Sciences
The Neuropharmacology subject builds on the basic concepts of neurophysiology and
neurotransmission to examine the role of neural communication in the regulation of
various neuropsychiatric disorders. Your goal will be to investigate the pathophysiology
of neuropsychiatric disorders and the ways in which these disorders are managed pharmacologically.
The pharmacology of the peripheral and central nervous systems. It examines neural
communication as a target for drug intervention, and how drugs may be used to relieve
pain, produce anaesthesia, regulate autonomic function, as well as control the symptoms
of various neuropsychiatric disorders. The subject also contains an introduction to
behavioural pharmacology and the mechanisms of drug addiction.
- approaches to studying behavioural pharmacology and its implications to therapeutic
drug development as well as the understanding of addictive and other behaviour patterns;
- current knowledge of the neurochemical basis of neurological disease and its treatment,
e.g. the use of neuroleptics in the treatment of schizophrenia;
- normal neuronal function and the targets at which neuronal function may be modified
- the neurobiology of pain and current strategies and future developments in the control
- current understanding of how genes and environment interact in the development of
||BC2024 and PP2101 and PP2201
Study Period 2
|Census Date 29-Aug-2019
||Professor Zoltan Sarnyai
||Dr Pam Megaw.
- 36 hours lectures
- 24 hours workshops/Seminars
||end of semester exam (60%); assignments (40%).
Minor variations might occur due to the continuous Subject quality improvement
process, and in case of
minor variation(s) in assessment details, the Subject Outline represents the latest